Ginkgo Bioworks Holdings, Inc. Operating Income Loss

• Ginkgo Bioworks Holdings, Inc. showed an increase of +43.7% in Operating Income Loss from 2024 to 2025.
• This data is from Ginkgo Bioworks Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2019 to 2025), Ginkgo Bioworks Holdings, Inc.'s Operating Income Loss has declined by 340.3%.
• Historical annual values: Fiscal year 2025: -$315.28 million | Fiscal year 2024: -$559.76 million | Fiscal year 2023: -$864.41 million | Fiscal year 2022: -$2.21 billion | Fiscal year 2021: -$1.83 billion | Fiscal year 2020: -$137.03 million | Fiscal year 2019: -$71.60 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026